Hybridization of non-sulfonylurea insulin secretagogue and thiazolidinedione-derived insulin sensitizer

Bioorg Med Chem Lett. 2000 Nov 6;10(21):2453-6. doi: 10.1016/s0960-894x(00)00491-1.

Abstract

Hybrid compounds of non-sulfonylurea insulinotropic agents and thiazolidinedione-derived insulin-sensitizing agents were designed and synthesized. The benzylidenesuccinic acid derivative 24 was equal both to nateglinide in potency of insulin-releasing activity and to pioglitazone in insulin-sensitizing activity.

MeSH terms

  • Animals
  • Benzylidene Compounds / chemical synthesis*
  • Benzylidene Compounds / chemistry
  • Benzylidene Compounds / pharmacology*
  • Cell Line
  • Dose-Response Relationship, Drug
  • Drug Design
  • Drug Evaluation, Preclinical
  • Hypoglycemic Agents / chemical synthesis*
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology*
  • Insulin / metabolism*
  • Insulin Secretion
  • Mice
  • Molecular Structure
  • Structure-Activity Relationship
  • Succinates / chemical synthesis*
  • Succinates / chemistry
  • Triglycerides / metabolism

Substances

  • Benzylidene Compounds
  • Hypoglycemic Agents
  • Insulin
  • Succinates
  • Triglycerides